Paper33972795
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Mitchell JM and 37 others. Nat Med, 2021. Cited by 655 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Papers, record 33972795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33972795
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug-Related Side Effects and Adverse Reactions | Major topic |
| N-Methyl-3,4-methylenedioxyamphetamine | Major topic |
| Stress Disorders, Post-Traumatic | Major topic |
| Adult | |
| Combined Modality Therapy | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R25 DA037756 | NIDA NIH HHS | United States | R25DA037756 | PubMed |
Source NIH RePORTER
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03537014 | A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) | Results | Yes | ClinicalTrials.gov |
| NCT05219175 | MDMA for Co-occurring PTSD and OUD After Childbirth | Results | ClinicalTrials.gov | |
| NCT05783817 | MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) | Results | ClinicalTrials.gov | |
| NCT05790239 | MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder | Background | ClinicalTrials.gov | |
| NCT06954025 | High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD | Results | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 34,031,606 | Putting the MD back into MDMA. | https://conductscience.org/library/papers/34031606 | PubMed |
| Comment in | 34,467,253 | Psychotherapy-supported MDMA treatment for PTSD. | https://conductscience.org/library/papers/34467253 | PubMed |
| Comment in | 34,635,856 | Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy. | https://conductscience.org/library/papers/34635856 | PubMed |
| Comment in | 34,635,857 | Challenges with benchmarking of MDMA-assisted psychotherapy. | https://conductscience.org/library/papers/34635857 | PubMed |
| Comment in | 34,635,858 | Caution at psychiatry's psychedelic frontier. | https://conductscience.org/library/papers/34635858 | PubMed |
References1
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|---|
| 1 | 10,450,264 | Posttraumatic stress disorder in abused and neglected children grown up. | Am J Psychiatry | 1999 | https://conductscience.org/library/papers/10450264 |
Source PubMed
Cited by417
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 655 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,974,518 | Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation. | Surg Neurol Int | 2026 | https://conductscience.org/library/papers/42974518 | PubMed |
| 42,972,049 | A multi-institutional investigation of psilocybin's effects on mouse behavior. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/42972049 | PubMed |
| 42,962,007 | The Fireside Database: Large-scale evidence from 25,419 psychedelic support interactions. | Sci Adv | 2026 | https://conductscience.org/library/papers/42962007 | PubMed |
| 42,891,831 | What goes up must comedown: prevalence rates, characteristics, and coping strategies concerning MDMA aftereffects. | Psychopharmacology (Berl) | 2026 | https://conductscience.org/library/papers/42891831 | PubMed |
| 42,875,076 | La psychothérapie assistée par des agents psychédéliques: Un paradigme émergent. | Can Fam Physician | 2026 | https://conductscience.org/library/papers/42875076 | PubMed |
| 42,875,067 | Psychedelic-assisted psychotherapy: Emerging paradigm. | Can Fam Physician | 2026 | https://conductscience.org/library/papers/42875067 | PubMed |
| 42,864,445 | Investigating molecular and hemodynamic effects of LSD in the human brain. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/42864445 | PubMed |
| 42,860,436 | A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD. | Neuropsychopharmacology | 2026 | https://conductscience.org/library/papers/42860436 | PubMed |
| 42,852,177 | Understanding pharmaceutical industry coalitions: a case study of Mallinckrodt. | Humanit Soc Sci Commun | 2026 | https://conductscience.org/library/papers/42852177 | PubMed |
| 42,851,356 | Effects of psychedelic drug use on neurocognitive function and the psychological and social domains of quality of life: an international online study. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42851356 | PubMed |
| 42,818,834 | Exploring the potential of psychedelics in brain injury recovery: a thematic analysis of participant narratives. | Front Neurol | 2026 | https://conductscience.org/library/papers/42818834 | PubMed |
| 42,812,288 | Lived experience as systems-relevant evidence in psychedelic public health. | Front Public Health | 2026 | https://conductscience.org/library/papers/42812288 | PubMed |
| 42,653,026 | Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42653026 | PubMed |
| 42,639,859 | Feasibility, Safety, and Exploratory Outcomes of Methylphenidate for Posttraumatic Stress Disorder Among Patients With Ischemic Stroke. | Int J Psychiatry Med | 2026 | https://conductscience.org/library/papers/42639859 | PubMed |
| 42,625,872 | Priorities for public health preparedness for psychedelics: education, workforce readiness, and strategic information needs in a rapidly changing landscape. | Front Public Health | 2026 | https://conductscience.org/library/papers/42625872 | PubMed |
| 42,625,811 | Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42625811 | PubMed |
| 42,581,324 | Well-being as a primary endpoint in clinical trials: a call for consensus. | Npj Ment Health Res | 2026 | https://conductscience.org/library/papers/42581324 | PubMed |
| 42,534,011 | Psychedelics for military and Veteran communities? Research, practice, and policy considerations. | J Mil Veteran Fam Health | 2023 | https://conductscience.org/library/papers/42534011 | PubMed |
| 42,533,988 | Mechanisms of integration in psychedelic-assisted therapy. | J Mil Veteran Fam Health | 2023 | https://conductscience.org/library/papers/42533988 | PubMed |
| 42,533,891 | A history and future of psychedelics: The case of the Canadian military. | J Mil Veteran Fam Health | 2023 | https://conductscience.org/library/papers/42533891 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| OXT | 5,020 | PubTator's text mining | https://conductscience.org/library/genes/5020 | NCBI Gene |
| SLC6A4 | 6,532 | PubTator's text mining | https://conductscience.org/library/genes/6532 | NCBI Gene |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| METHAMPHETAMINE | CHEMBL1201201 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201201 | ChEMBL |
| MIDOMAFETAMINE | CHEMBL43048 | Results | 4 | https://conductscience.org/library/drugs/CHEMBL43048 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33972795
GET https://conductscience.org/api/papers/v1/33972795/authors?page=2